HLTH
Not rated
No published distribution safety rating is available.
ETF Comparison
HLTH vs IHI: Which Is the Better Pick in 2026?
A head-to-head comparison of Tema Healthcare AI ETF and iShares U.S. Medical Devices ETF covering yield, cost, risk, and income potential.
Updated November 6, 2026
No track record yet. HLTH launched within the last six months. The forward distribution rate is left blank until a payout is published.
How these figures are calculated: methodology.
Price and total return
Compare the same available dates. Add a ticker or benchmark below; these controls change the chart only. The snapshot and article describe the original comparison.
Interactive history loads here. The snapshot and period returns remain available when chart history cannot be loaded.
Distribution Safety Score
An estimate of distribution reliability, not price or principal safety, a probability, or a guarantee. Score methodology.
IHI
Generally safe
High confidence
Score snapshot as of . Method 1.11.
Side-by-side snapshot
| Metric |  HLTH |  IHI |
|---|---|---|
| Full name | Tema Healthcare AI ETF | iShares U.S. Medical Devices ETF |
| Issuer | Tema ETFs | iShares |
| Last Close | $26.95 as of November 6, 2026 | $57.59 as of November 6, 2026 |
| Distribution rate | — | 0.56% |
| Trailing 12-month yield | — | 0.45% |
| Distribution Safety Score™ | — | 79 |
| Safety-Adjusted Yield | — | 0.44% |
| Expense ratio | 0.75% | 0.37% |
| AUM | $11.7M | $3.61B |
| Distribution frequency | None | Quarterly |
| Underlying index | Actively managed (no tracked index recorded) | — |
| Objective | Seeks long-term capital appreciation through an actively managed portfolio of companies applying artificial intelligence across healthcare — including AI-driven drug discovery, diagnostics, medical imaging, medical devices, and healthcare IT platforms. | — |
| Asset class | Equity | Equity |
| Inception date | 07/21/2026 | 05/01/2006 |
| Beta | — | 0.77 |
| Last dividend | — | $0.081 |
| Ex-dividend date | — | 09/15/2026 |
— Distribution rate, Safety-Adjusted Yield, last dividend, and ex-dividend date are not yet available because HLTH launched July 2026; these fields will populate after the first distribution.
Total returns
100% reinvested · ex-date convention. Period returns use this fixed assumption, independent of chart settings. YTD and 1Y are cumulative period returns; 3Y, 5Y, and 10Y are annualized. The shared Since-start window is annualized only when it covers at least one year.
HLTH has outpaced IHI over the year to date, posting a 5.60% total return against -4.65%. IHI has been the steadier holding, though — annualized volatility of 23.9% against 35.9% for HLTH. Figures are total returns: price change plus every distribution reinvested.
| Symbol | YTD cumulative | Since Jul 2026 | Volatility | Sharpe | Sortino | Max drawdown |
|---|---|---|---|---|---|---|
| HLTH | 5.60% | 5.60% | 35.9% | 0.39 | 0.52 | -12.6% |
| IHI | -4.65% | 18.36% | 23.9% | 2.17 | 4.09 | -10.8% |
Total return with all distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date), split-adjusted, as of November 5, 2026. YTD and 1Y are cumulative period returns; 3Y, 5Y, and 10Y are annualized. The shared Since-start window is annualized only when it covers at least one year. “Since Jul 2026” measures every fund from July 21, 2026 — the start of shared available history — so all funds share one comparison window. Volatility is the annualized standard deviation of daily total returns over the shared window since Jul 2026. Sharpe and Sortino divide the annualized return in excess of the risk-free rate by, respectively, that volatility and the downside deviation (both over the shared window since Jul 2026) — higher is better. Max drawdown is the largest peak-to-trough total-return decline over the same window — shallower is better.
Not a distribution payer
HLTH (Tema Healthcare AI ETF) has no distribution rate on file and its distribution frequency is None. HLTH is not a payer. The blank yield is not a zero yield.
Visual comparison
Key metrics
Projected income on $10K
Projections assume the current yield and share price remain constant. Actual results will vary.
Bottom lineWe won't call this one: HLTH launched July 2026, so there is not yet a track record to compare. Compare the strategy, cost and holdings in the sections above and treat any performance figures for the newer ETF as provisional. What is already clear from the numbers above: the two do not cost the same — IHI charges 0.37% against 0.75% for HLTH, and on funds tracking the same thing that gap compounds every year you hold.
Income calculator
See how much monthly income a hypothetical investment would generate in each ETF at current yields.
ETFs15
Total AUM$4.23B
ETFs and AUM reflect what Dividend Vision tracks — the issuer's full lineup may be larger.
Tema ETFs is known for offering thematically focused and income-oriented strategies that target specific industries and trends rather than broad market exposure. The issuer's lineup spans both income-generating funds and thematic investments centered on sectors such as defense, healthcare, technology, and infrastructure, with tickers including ARMY, CANC, DSPY, HLTH, LAZR, NASA, and VOLT. Tema's approach appeals to investors seeking targeted exposure to niche market segments, combining specialized industry focus with dividend and yield strategies.
See our curated list of related YouTube videos on HLTH.
ETFs468
Total AUM$4.63T
ETFs and AUM reflect what Dividend Vision tracks — the issuer's full lineup may be larger.
iShares, operated by BlackRock, is one of the largest and most established ETF providers globally, known for offering broad, liquid index-tracking funds across nearly all asset classes and investment styles. The lineup encompasses a comprehensive range of strategies including core equity and bond exposure, dividend and income-focused funds, covered call strategies, ESG and thematic investments, factor-based approaches, alternatives, commodities, and municipal bonds, serving both individual and institutional investors. With numerous popular ticker symbols and extensive diversification across geographies, sectors, and investment objectives, iShares provides one of the market's widest selections of ETFs for building diversified portfolios.
See our curated list of related YouTube videos on IHI.
Quick verdict
HLTH (Tema Healthcare AI ETF) and IHI (iShares U.S. Medical Devices ETF) are both ETFs, but they take different approaches.
IHI currently shows a 0.56% distribution yield. HLTH has not yet established a full distribution history, so a comparable yield figure is not available.
IHI is cheaper with an expense ratio of 0.37% compared to 0.75%.
IHI has $3.61B in assets vs $11.7M for HLTH, but HLTH only launched July 2026 — AUM comparisons will become more meaningful as it builds a track record.
Top-holdings overlap
Positions that appear in every fund's top 10. Issuers disclose only the largest weights, so this captures the overlap of the concentrated end of each book — not the full portfolios.
1 shared position
HLTH 4.4% of its top-10 weight
IHI 15.0% of its top-10 weight
| Position | HLTH | IHI |
|---|---|---|
| ISRG Intuitive Surgical Inc |
Deep dive
Yield & income
On a $10,000 investment at current distribution rates, HLTH has no reported distribution yield yet, so a cash estimate is not available, while IHI would pay about $56.00 a year (about $14.00 per quarterly distribution).
HLTH yield—
IHI yield0.56%
Cost & efficiency
Over 10 years on $10,000, HLTH would cost approximately $750 in fees vs $370 for IHI (simplified, not compounded). The $380.00 difference may be offset by yield or performance.
HLTH ER0.75%
IHI ER0.37%
Strategy & risk
HLTH is an actively managed ETF built around healthcare exposure, while IHI is an ETF built around healthcare exposure.
HLTH beta—
IHI beta0.77
Fund details
HLTH is managed by Tema ETFs (launched 07/21/2026) with $11.7M in assets. IHI is managed by iShares (launched 05/01/2006) with $3.61B in assets.
HLTH AUM$11.7M
IHI AUM$3.61B
Frequently asked questions
Which of HLTH or IHI pays more dividend income?
IHI currently reports a distribution yield, while HLTH has not yet established a full distribution history. A direct income comparison is not yet meaningful — check back once both funds have published several consecutive distributions.
What is the difference between HLTH and IHI?
HLTH (Tema Healthcare AI ETF) is an actively managed ETF built around healthcare exposure, while IHI (iShares U.S. Medical Devices ETF) is an ETF built around healthcare exposure. They are issued by Tema ETFs and iShares respectively.
Can I hold both HLTH and IHI?
Yes. Their disclosed top-10 holdings share only 1 position, so combining both adds mostly distinct underlying names — see the holdings-overlap section above. Overlap outside the disclosed top 10 can still exist.
Which has lower fees, HLTH or IHI?
HLTH has an expense ratio of 0.75% while IHI charges 0.37%. Lower fees mean more of your investment returns stay in your pocket over time.
How much income does $10,000 in HLTH vs IHI generate?
At current distribution rates, HLTH does not pay distributions, so there is no cash income to estimate. $10,000 in IHI would pay about $56.00 a year (about $14.00 per quarterly distribution).
Which has performed better historically, HLTH or IHI?
HLTH has outpaced IHI over the year to date, posting a 5.60% total return against -4.65%. IHI has been the steadier holding, though — annualized volatility of 23.9% against 35.9% for HLTH. Figures are total returns: price change plus every distribution reinvested. Past performance does not guarantee future results.
More comparisons to explore
People also compare HLTH with
People also compare IHI with
Popular comparisons
HLTH vs IHI — at a glance
Generated October 31, 2026.
Figures quoted in this analysis are from its generation date and may lag the live snapshot table above, which always shows the latest data.
Overview
HLTH and IHI both invest in U.S. healthcare equities but pursue fundamentally different strategies. HLTH is an actively managed fund that targets companies deploying artificial intelligence across drug discovery, diagnostics, imaging, devices, and healthcare IT. IHI is a passive fund tracking medical device manufacturers specifically. The distinction matters: HLTH bets on AI-driven innovation across the broader healthcare ecosystem, while IHI isolates a narrower hardware-and-equipment subsector.
How they differ
The biggest difference is mandate. HLTH explicitly seeks companies applying AI technology to healthcare challenges—a thematic tilt toward innovation and software-enabled platforms. IHI tracks an index of medical device companies, which may include some AI adoption but centers on traditional device hardware, orthopedics, diagnostics equipment, and surgical tools. HLTH charges 0.75%, reflecting active management; IHI costs 0.37%, a typical passive expense ratio 0.38% higher. IHI has a $3.61B asset base and a 20 years track record (inception 05/01/2006), while HLTH holds just $11.7M and launched 07/21/2026.
Who each is best for
- HLTH: Fits investors who want concentrated exposure to healthcare innovation driven by AI adoption and are comfortable with an emerging, thinly capitalized active strategy that may experience wider price swings and less trading liquidity than established competitors.
- IHI: Fits investors seeking broad, lower-cost access to the medical device sector with a long track record, quarterly income, and the stability that comes with an index-based approach and a much larger asset base. Small AUM also increases the risk of fund closure or restructuring.
- Active management and tracking error (HLTH). Actively managed healthcare AI selection introduces manager-dependent performance variance; there is no guarantee the fund's stock picks will beat the underlying healthcare or AI benchmarks it implicitly competes against.
- Sector cyclicality and valuation sensitivity. Both funds hold healthcare equities that can experience sharp drawdowns during economic downturns, rising interest rates, or healthcare policy shifts. Device and AI-healthcare valuations can compress rapidly if growth expectations recede.
- AI enthusiasm without earnings proof (HLTH). Many companies claimed to employ AI in healthcare have not yet commercialized those efforts into meaningful revenue or profit. HLTH's holdings may face execution risk if AI investments don't translate to clinical adoption or reimbursement.
- Index constituent turnover (IHI). As an index fund, IHI's holdings will reflect changes in the medical device index methodology, which may lead to forced buys and sells that incur small tax drag in non-sheltered accounts.
Bottom line
If you want diversified, seasoned exposure to medical devices with minimal fees and a quarterly dividend, IHI's index approach and 18-year history offer simplicity and liquidity. Past performance does not predict future results; the manager's ability to identify AI winners in healthcare remains unproven.
AI-generated analysis for educational purposes only. Verify important details independently; past performance does not guarantee future results.
Learn the method
The metrics behind this comparison, explained in the Academy.
These comparisons follow the Dividend Vision methodology.